POAI Predictive Oncology Inc
Price (delayed)
$1.34
Market cap
$11.97M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.32
Enterprise value
$13.36M
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
Highlights
The EPS has increased by 33% YoY and by 24% from the previous quarter
The company's debt fell by 22% YoY and by 11% QoQ
POAI's gross profit is up by 36% since the previous quarter but it is down by 22% year-on-year
Predictive Oncology's gross margin has decreased by 22% YoY but it has increased by 14% QoQ
Predictive Oncology's equity has shrunk by 110% QoQ and by 102% YoY
Predictive Oncology's quick ratio has shrunk by 82% YoY and by 56% QoQ
Key stats
What are the main financial stats of POAI
Market
Valuations
Earnings
Shares outstanding
8.93M
Market cap
$11.97M
Enterprise value
$13.36M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
4.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.23
Revenue
$1.62M
Gross profit
$797,680
Operating income
-$10.95M
Net income
-$12.66M
EBIT
-$12.66M
EBITDA
-$11.97M
Free cash flow
-$11.97M
Per share
Balance sheet
Liquidity
EPS
-$2.32
EPS diluted
-$2.32
Free cash flow per share
-$2.19
Book value per share
-$0.03
Revenue per share
$0.3
TBVPS
$0.87
Total assets
$4.97M
Total liabilities
$5.18M
Debt
$2.13M
Equity
-$202,610
Working capital
-$1.37M
Debt to equity
-10.52
Current ratio
0.62
Quick ratio
0.41
Net debt/EBITDA
-0.12
Margins
Efficiency
Dividend
EBITDA margin
-737.1%
Gross margin
49.1%
Net margin
-779.9%
Operating margin
-674.4%
Return on assets
-150.5%
Return on equity
-511.1%
Return on invested capital
-433.4%
Return on capital employed
-918.3%
Return on sales
-779.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
POAI stock price
How has the Predictive Oncology stock price performed over time
Intraday
-2.19%
1 week
-7.59%
1 month
3.88%
1 year
-31.63%
YTD
63.41%
QTD
-11.84%
Financial performance
How have Predictive Oncology's revenue and profit performed over time
Revenue
$1.62M
Gross profit
$797,680
Operating income
-$10.95M
Net income
-$12.66M
Gross margin
49.1%
Net margin
-779.9%
POAI's gross profit is up by 36% since the previous quarter but it is down by 22% year-on-year
POAI's operating margin is up by 28% since the previous quarter and by 10% year-on-year
The company's net margin rose by 24% QoQ and by 9% YoY
Predictive Oncology's gross margin has decreased by 22% YoY but it has increased by 14% QoQ
Growth
What is Predictive Oncology's growth rate over time
Valuation
What is Predictive Oncology stock price valuation
P/E
N/A
P/B
N/A
P/S
4.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.23
The EPS has increased by 33% YoY and by 24% from the previous quarter
Predictive Oncology's equity has shrunk by 110% QoQ and by 102% YoY
The P/S is 77% lower than the 5-year quarterly average of 19.8 but 22% higher than the last 4 quarters average of 3.7
POAI's revenue is up by 19% from the previous quarter
Efficiency
How efficient is Predictive Oncology business performance
The return on assets has dropped by 111% year-on-year and by 16% since the previous quarter
The company's return on equity has shrunk by 68% QoQ
Predictive Oncology's ROIC has plunged by 52% YoY and by 3.5% from the previous quarter
The ROS has increased by 24% from the previous quarter and by 9% YoY
Dividends
What is POAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for POAI.
Financial health
How did Predictive Oncology financials performed over time
The company's total assets is 3.9% lower than its total liabilities
Predictive Oncology's quick ratio has shrunk by 82% YoY and by 56% QoQ
The current ratio has dropped by 76% year-on-year and by 48% since the previous quarter
Predictive Oncology's equity has shrunk by 110% QoQ and by 102% YoY
The company's debt fell by 22% YoY and by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.